Riverbridge Partners LLC reduced its stake in OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) by 11.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 390,774 shares of the company’s stock after selling 52,295 shares during the quarter. Riverbridge Partners LLC’s holdings in OrthoPediatrics were worth $9,058,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the stock. Quarry LP purchased a new position in OrthoPediatrics during the 3rd quarter worth $25,000. International Assets Investment Management LLC boosted its holdings in shares of OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after acquiring an additional 966 shares in the last quarter. BNP Paribas Financial Markets increased its stake in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after acquiring an additional 1,929 shares during the period. Quantbot Technologies LP raised its holdings in OrthoPediatrics by 42.2% during the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after purchasing an additional 1,712 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C acquired a new stake in OrthoPediatrics in the second quarter valued at about $203,000. Institutional investors and hedge funds own 69.05% of the company’s stock.
Wall Street Analyst Weigh In
KIDS has been the topic of several recent analyst reports. Truist Financial dropped their target price on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Needham & Company LLC reissued a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Tuesday, January 14th.
OrthoPediatrics Price Performance
Shares of OrthoPediatrics stock opened at $27.12 on Thursday. The company has a 50-day moving average of $24.15 and a two-hundred day moving average of $27.28. OrthoPediatrics Corp. has a 12-month low of $21.02 and a 12-month high of $35.99. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.
OrthoPediatrics Company Profile
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Further Reading
- Five stocks we like better than OrthoPediatrics
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Tide Shifts for 3M: How to Profit from the Rally
- What is the S&P 500 and How It is Distinct from Other Indexes
- Palantir Technologies: Another Stellar Year Ahead for the Stock?
- What is a Death Cross in Stocks?
- 2 ETFs to Maximize Gains With Covered Call Strategies
Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report).
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.
